High Degree of Genetic Heterogeneity for Hereditary Cerebellar Ataxias in Australia
Genetic testing strategies such as next-generation sequencing (NGS) panels and whole genome sequencing (WGS) can be applied to the hereditary cerebellar ataxias (HCAs), but their exact role in the diagnostic pathway is unclear. We aim to determine the yield from genetic testing strategies and the genetic and phenotypic spectrum of HCA in Australia by analysing real-world data. We performed a retrospective review on 87 HCA cases referred to the Neurogenetics Clinic at the Royal North Shore Hospital, Sydney, Australia. Probands underwent triplet repeat expansion testing; those that tested negative had NGS-targeted panels and WGS testing when available. In our sample, 58.6% were male (51/87), with an average age at onset of 37.1 years. Individuals with sequencing variants had a prolonged duration of illness compared to those with a triplet repeat expansion. The detection rate in probands for routine repeat expansion panels was 13.8% (11/80). NGS-targeted panels yielded a further 11 individuals (11/32, 34.4%), with WGS yielding 1 more diagnosis (1/3, 33.3%). NGS panels and WGS improved the overall diagnostic rate to 28.8% (23/80) in 14 known HCA loci. The genetic findings included novel variants in ANO10, CACNA1A, PRKCG and SPG7. Our findings highlight the genetic heterogeneity of HCAs and support the use of NGS approaches for individuals who were negative on repeat expansion testing. In comparison to repeat disorders, individuals with sequencing variants may have a prolonged duration of illness, consistent with slower progression of disease.
|Authors||Kang, C.; Liang, C.; Ahmad, K. E.; Gu, Y.; Siow, S. F.; Colebatch, J. G.; Whyte, S.; Ng, K.; Cremer, P. D.; Corbett, A. J.; Davis, R. L.; Roscioli, T.; Cowley, M. J.; Park, J. S.; Sue, C. M.; Kumar, K. R.|
|Responsible Garvan Author||Dr Kishore Kumar|
|URL link to publisher's version||https://www.ncbi.nlm.nih.gov/pubmed/30078120|